BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

391 related articles for article (PubMed ID: 34160433)

  • 1. Seroprevalence of SARS-CoV-2 antibodies among 925 staff members in an urban hospital accepting COVID-19 patients in Osaka prefecture, Japan: A cross-sectional study.
    Nishida T; Iwahashi H; Yamauchi K; Kinoshita N; Okauchi Y; Suzuki N; Inada M; Abe K
    Medicine (Baltimore); 2021 Jun; 100(25):e26433. PubMed ID: 34160433
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comprehensive infection control measures prevent hospital-acquired severe acute respiratory syndrome coronavirus 2 infection: A single-center prospective cohort study and seroprevalence survey.
    Hori H; Fukuchi T; Sanui M; Moriya T; Sugawara H
    PLoS One; 2021; 16(10):e0257513. PubMed ID: 34634076
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Seroprevalence of anti-SARS-CoV-2 IgG/IgM antibodies in Borgosesia (Piedmont Region, Northern Italy) population: a surveillance strategy in post-lockdown period?].
    Alessi D; Borré S; Barale A; Isabella A; Milano F; Rossi MA; Silano V; Piu N; Cena T; Faggiano F;
    Epidemiol Prev; 2020; 44(5-6 Suppl 2):200-206. PubMed ID: 33412811
    [TBL] [Abstract][Full Text] [Related]  

  • 4. SARS-CoV-2 antibody seroprevalence in the general population and high-risk occupational groups across 18 cities in Iran: a population-based cross-sectional study.
    Poustchi H; Darvishian M; Mohammadi Z; Shayanrad A; Delavari A; Bahadorimonfared A; Eslami S; Javanmard SH; Shakiba E; Somi MH; Emami A; Saki N; Hormati A; Ansari-Moghaddam A; Saeedi M; Ghasemi-Kebria F; Mohebbi I; Mansour-Ghanaei F; Karami M; Sharifi H; Pourfarzi F; Veisi N; Ghadimi R; Eghtesad S; Niavarani A; Ali Asgari A; Sadeghi A; Sorouri M; Anushiravani A; Amani M; Kaveh S; Feizesani A; Tabarsi P; Keyvani H; Markarian M; Shafighian F; Sima A; Sadjadi A; Radmard AR; Mokdad AH; Sharafkhah M; Malekzadeh R
    Lancet Infect Dis; 2021 Apr; 21(4):473-481. PubMed ID: 33338441
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Seroprevalence of and Risk Factors Associated With SARS-CoV-2 Infection in Health Care Workers During the Early COVID-19 Pandemic in Italy.
    Poletti P; Tirani M; Cereda D; Guzzetta G; Trentini F; Marziano V; Toso C; Piatti A; Piccarreta R; Melegaro A; Andreassi A; Gramegna M; Ajelli M; Merler S
    JAMA Netw Open; 2021 Jul; 4(7):e2115699. PubMed ID: 34228126
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Seroprevalence of Anti-SARS-CoV-2 Antibodies in Blood Donors from Nuevo Leon State, Mexico, during 2020: A Retrospective Cross-Sectional Evaluation.
    Martinez-Acuña N; Avalos-Nolazco DM; Rodriguez-Rodriguez DR; Martinez-Liu CG; Galan-Huerta KA; Padilla-Rivas GR; Ramos-Jimenez J; Ayala-de-la-Cruz S; Cienfuegos-Pecina E; Diaz-Chuc EA; Cazares-Tamez R; Flores-Arechiga A; Perez-Chavez F; Arellanos-Soto D; Lozano-Sepulveda SA; Garza-Gonzalez E; Treviño-Garza C; Montes-de-Oca-Luna R; Lee-Gonzalez AB; de-la-O-Cavazos ME; Rivas-Estilla AM
    Viruses; 2021 Jun; 13(7):. PubMed ID: 34202849
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Seroprevalence of anti-SARS-CoV-2 IgG antibodies pre- and post-COVID-19 vaccination in staff members of Bandar Abbas Children's Hospital.
    Tariverdi M; Mohammadi H; Hassanzadeh F; Tamaddondar M
    BMC Infect Dis; 2024 Feb; 24(1):253. PubMed ID: 38395759
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Seroprevalence of SARS-CoV-2 antibodies and associated factors in healthcare workers: a systematic review and meta-analysis.
    Galanis P; Vraka I; Fragkou D; Bilali A; Kaitelidou D
    J Hosp Infect; 2021 Feb; 108():120-134. PubMed ID: 33212126
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Seroprevalence of severe acute respiratory coronavirus virus 2 (SARS-CoV-2) antibodies among healthcare workers with differing levels of coronavirus disease 2019 (COVID-19) patient exposure.
    Hunter BR; Dbeibo L; Weaver CS; Beeler C; Saysana M; Zimmerman MK; Weaver L
    Infect Control Hosp Epidemiol; 2020 Dec; 41(12):1441-1442. PubMed ID: 32741406
    [TBL] [Abstract][Full Text] [Related]  

  • 10. SARS-CoV-2 transmission among children and staff in daycare centres during a nationwide lockdown in France: a cross-sectional, multicentre, seroprevalence study.
    Lachassinne E; de Pontual L; Caseris M; Lorrot M; Guilluy C; Naud A; Dommergues MA; Pinquier D; Wannepain E; Hausherr E; Jung C; Gajdos V; Cohen R; Zahar JR; Brichler S; Basmaci R; Boelle PY; Bloch-Queyrat C; Aupiais C;
    Lancet Child Adolesc Health; 2021 Apr; 5(4):256-264. PubMed ID: 33571450
    [TBL] [Abstract][Full Text] [Related]  

  • 11. SARS-CoV-2 seroprevalence and asymptomatic viral carriage in healthcare workers: a cross-sectional study.
    Shields A; Faustini SE; Perez-Toledo M; Jossi S; Aldera E; Allen JD; Al-Taei S; Backhouse C; Bosworth A; Dunbar LA; Ebanks D; Emmanuel B; Garvey M; Gray J; Kidd IM; McGinnell G; McLoughlin DE; Morley G; O'Neill J; Papakonstantinou D; Pickles O; Poxon C; Richter M; Walker EM; Wanigasooriya K; Watanabe Y; Whalley C; Zielinska AE; Crispin M; Wraith DC; Beggs AD; Cunningham AF; Drayson MT; Richter AG
    Thorax; 2020 Dec; 75(12):1089-1094. PubMed ID: 32917840
    [TBL] [Abstract][Full Text] [Related]  

  • 12. SARS-CoV-2 seroprevalence trends in healthy blood donors during the COVID-19 outbreak in Milan.
    Valenti L; Bergna A; Pelusi S; Facciotti F; Lai A; Tarkowski M; Lombardi A; Berzuini A; Caprioli F; Santoro L; Baselli G; Ventura CD; Erba E; Bosari S; Galli M; Zehender G; Prati D;
    Blood Transfus; 2021 May; 19(3):181-189. PubMed ID: 33539289
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Seroprevalence of anti-SARS-CoV-2 IgG antibodies in the staff of a public school system in the midwestern United States.
    Lopez L; Nguyen T; Weber G; Kleimola K; Bereda M; Liu Y; Accorsi EK; Skates SJ; Santa Maria JP; Smith KR; Kalinich M
    PLoS One; 2021; 16(6):e0243676. PubMed ID: 34111144
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Seroprevalence of SARS-CoV-2 antibodies among hospital staff in rural Central Fukushima, Japan: A historical cohort study.
    Kobashi Y; Nishikawa Y; Kawamura T; Kodama T; Shimazu Y; Obara D; Zhao T; Tsubokura M
    Int Immunopharmacol; 2021 Sep; 98():107884. PubMed ID: 34246041
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prevalence of IgG antibodies against SARS-CoV-2 among healthcare workers in a tertiary pediatric hospital in Poland.
    Kasztelewicz B; Janiszewska K; Burzyńska J; Szydłowska E; Migdał M; Dzierżanowska-Fangrat K
    PLoS One; 2021; 16(4):e0249550. PubMed ID: 33793673
    [TBL] [Abstract][Full Text] [Related]  

  • 16. SARS-CoV-2 Seroprevalence Structure of the Russian Population during the COVID-19 Pandemic.
    Popova AY; Smirnov VS; Andreeva EE; Babura EA; Balakhonov SV; Bashketova NS; Bugorkova SA; Bulanov MV; Valeullina NN; Vetrov VV; Goryaev DV; Detkovskaya TN; Ezhlova EB; Zaitseva NN; Istorik OA; Kovalchuk IV; Kozlovskikh DN; Kombarova SY; Kurganova OP; Lomovtsev AE; Lukicheva LA; Lyalina LV; Melnikova AA; Mikailova OM; Noskov AK; Noskova LN; Oglezneva EE; Osmolovskaya TP; Patyashina MA; Penkovskaya NA; Samoilova LV; Stepanova TF; Trotsenko OE; Totolian AA
    Viruses; 2021 Aug; 13(8):. PubMed ID: 34452512
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Difference in SARS-CoV-2 Antibody Status Between Patients With Cancer and Health Care Workers During the COVID-19 Pandemic in Japan.
    Yazaki S; Yoshida T; Kojima Y; Yagishita S; Nakahama H; Okinaka K; Matsushita H; Shiotsuka M; Kobayashi O; Iwata S; Narita Y; Ohba A; Takahashi M; Iwasa S; Kobayashi K; Ohe Y; Yoshida T; Hamada A; Doi T; Yamamoto N
    JAMA Oncol; 2021 Aug; 7(8):1141-1148. PubMed ID: 34047762
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prevalence of SARS-CoV-2 IgG antibodies in an area of northeastern Italy with a high incidence of COVID-19 cases: a population-based study.
    Stefanelli P; Bella A; Fedele G; Pancheri S; Leone P; Vacca P; Neri A; Carannante A; Fazio C; Benedetti E; Fiore S; Fabiani C; Simmaco M; Santino I; Zuccali MG; Bizzarri G; Magnoni R; Benetollo PP; Merler S; Brusaferro S; Rezza G; Ferro A
    Clin Microbiol Infect; 2021 Apr; 27(4):633.e1-633.e7. PubMed ID: 33253941
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Seroprevalence of SARS-CoV-2 IgG antibodies and risk factors in health care workers at an academic medical center in Boston, Massachusetts.
    Kataria Y; Cole M; Duffy E; de la Cena K; Schechter-Perkins EM; Bouton TC; Werler MM; Pierre C; Ragan EJ; Weber SE; Jacobson KR; Andry C
    Sci Rep; 2021 May; 11(1):9694. PubMed ID: 33958668
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Seroprevalence Surveys for Anti-SARS-CoV-2 Antibody in Different Populations in Taiwan With Low Incidence of COVID-19 in 2020 and Severe Outbreaks of SARS in 2003.
    Tseng WP; Wu JL; Wu CC; Kuo KT; Lin CH; Chung MY; Lee YF; Yang BJ; Huang CH; Chen SY; Yu CJ; Chen SC; Hsueh PR
    Front Immunol; 2021; 12():626609. PubMed ID: 34084161
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.